ART does not eliminate HIV-2 from the body, but consistent treatment can reduce viral activity and help preserve immune function. Starting treatment early and maintaining regular medical care are important aspects of managing the infection.
ART aims to suppress viral replication and protect immune cells.
HIV-2 requires specific medication choices because of differences in drug susceptibility.
Early treatment can help reduce the risk of immune system deterioration.
Consistent medication use supports long-term treatment effectiveness.
HIV-2 treatment typically uses a combination of antiretroviral medications that are active against the virus. Integrase inhibitors, combined with two nucleoside reverse transcriptase inhibitors, are commonly used in treatment regimens. Certain protease inhibitors may also be considered depending on clinical circumstances, while non-nucleoside reverse transcriptase inhibitors are generally ineffective against HIV-2.
Monitoring helps healthcare professionals assess treatment response, immune function, and possible complications. HIV-2 viral load testing may be less widely available than HIV-1 testing, so clinicians may also consider CD4 cell counts and clinical changes when evaluating treatment progress.
Integrase inhibitors are important components of many HIV-2 treatment regimens.
Medication selection considers resistance, tolerability, and individual medical needs.
CD4 cell counts help assess immune system health.
Regular follow-ups help identify side effects, adherence concerns, or treatment challenges.
Understanding HIV-2 treatment approaches helps patients recognize the importance of individualized care, appropriate medication combinations, and continuous monitoring in maintaining health and managing the infection over time.